Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 8
Submit an article Journal homepage
135
Views
2
CrossRef citations to date
0
Altmetric
Original Article

The intraocular pressure reducing effect of brinzolamide as adjunctive therapy to latanoprost

Dr James F.T. Li YimGlasgow Royal Infirmary, Glasgow, Scotland, United KingdomCorrespondence[email protected]
&
Dr Donald M. MontgomeryGlasgow Royal Infirmary, Glasgow, Scotland, United Kingdom
Pages 1499-1502 | Accepted 03 May 2011, Published online: 09 Jun 2011

References

  • NICE clinical guideline 85 Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension. Available at: http://www.nice.org.uk/nicemedia/live/12145/43839/43839.pdf (Last accessed 2 November 2010)
  • Toris CB, Camras CB, Yablonski ME. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes. Ophthalmology 1993;100:1297-304
  • European medicine agency Brinzolamide Doc. Ref: EMA/793685/2009 EMEA/H/C/267. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000267/WC500030360.pdf (Last accessed 2 November 2010)
  • Shoji N, Ogata H, Suyama H, et al. Intraocular pressure lowering effect of brinzolamide 1.0% as adjunctive therapy to latanoprost 0.005% in patients with open angle glaucoma or ocular hypertension: an uncontrolled, open-label study. Curr Med Res Opin 2005;21:503-8
  • Abe K, Kashiwagi K. Additive effect of brinzolamide on diurnal changes in intraocular pressure in latanoprost-treated eyes. Open Ophthalmol J 2008;2:160-4
  • Miura K, Ito K, Okawa C, et al. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost. J Glaucoma 2008;17:233-7
  • Day DG, Hollander DA. Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension. Curr Med Res Opin 2008;24:1435-42
  • Bournias TE, Lai J. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs. Ophthalmology 2009;116:1719-24
  • Nakamura Y, Ishikawa S, Nakamura Y, et al. 24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost. Clin Ophthalmol 2009;3:395-400
  • Rahman MQ, Montgomery DM, Lazaridou MN. Surveillance of glaucoma medical therapy in a Glasgow teaching hospital: 26 years’ experience. Br J Ophthalmol 2009;93:1572-5
  • Leskea MC, Heijl A, Hyman L, et al. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial. Curr Opin Ophthalmol 2004;15:102-6
  • Sall K. The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group. Surv Ophthalmol 2000;44(Suppl 2):S155-62

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.